Skip to content

Comparison of integrated collaborative telepsychiatry with enhanced referral telepsychiatry in psychiatric patients

Comparison of the effectiveness of integrated collaborative telepsychiatry with enhanced referral telepsychiatry on improving performance, disability, medication compliance, and satisfaction of psychiatric patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230112057116N4
Enrollment
60
Registered
2025-06-07
Start date
2025-06-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Mood [affective] disorders. Condition 2: Anxiety disorders. Condition 3: Bipolar affective disorder. Major depressive disorder, single episode Phobic anxiety disorders Bipolar disorder

Interventions

Intervention 1: Intervention group1: Collaborative telepsychiatry:In collaborative care (Tele psychiatry collaborative care), an effective interaction is established between the patient and the treatm

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years old. Patients diagnosed with psychiatric disorders based on the national mental health care guidelines. A patient diagnosed who has discontinued their treatment There should be the possibility and ability to communicate with the patient via phone and the internet.

Exclusion criteria

Exclusion criteria: The patient should have serious medical comorbidities.

Design outcomes

Primary

MeasureTime frame
Disability assessment. Timepoint: disability assessment before intervention and 6 months and 12 months after intervention. Method of measurement: World Health Organization Disability Assessment Schedule (WHODAS-2.0).;Global Assessment of Functioning. Timepoint: Global Assessment of Functioning (GAF)before intervention and 6 months and 12 months after intervention. Method of measurement: Global Assessment of Functioning (GAF) questionare.;Clinical Global Impression-Improvement. Timepoint: before intervention and 6 months and 12 months after intervention. Method of measurement: Clinical Global Impression-Improvement scale (CGI-I).

Secondary

MeasureTime frame
Medication adherence. Timepoint: before intervention and 6 months and 12 months after intervention. Method of measurement: medication adherence report scale (MARS).;Suicide rate. Timepoint: before intervention and 6 months and 12 months after intervention. Method of measurement: patient and family self report.;Patient satisfaction with telepsychiatry services. Timepoint: before intervention and 6 months and 12 months after intervention. Method of measurement: satisfaction questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPeigham Heidarpoor

Shahid Beheshti University of Medical Sciences

info@sbmu.ac.ir+98 21 2621 0092

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026